Moreover, p-AKT expression levels are found to be upregulated in EGFR-TKI resistant cell lines compared to their corresponding parental cell lines [31, 32], and upregulation of p-AKT confers EGFR-TKI resistance in EGFR-mutant lung cancers [33, 34]. Here, AKT1 is linked to lung carcinoma.